Last reviewed · How we verify
Hermaphrodiol (androstenediol)
Hermaphrodiol (generic name: androstenediol) is a androstenediol drug. It is currently in unknown development.
Hermaphrodiol works by binding to sex hormone-binding globulin, a protein that regulates the levels of sex hormones in the body.
Androstenediol is an endogenous steroid hormone that serves as an intermediate in the biosynthesis of testosterone from dehydroepiandrosterone (DHEA). It is a weak androgen and estrogen, closely related to androstenedione.
At a glance
| Generic name | androstenediol |
|---|---|
| Drug class | androstenediol |
| Target | Corticosteroid-binding globulin, Sex hormone-binding globulin, Androgen receptor |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Think of sex hormone-binding globulin like a 'lock' that holds onto sex hormones, like a key. Hermaphrodiol is like a 'key' that binds to this 'lock', releasing the sex hormones and allowing them to do their job. This can help increase the levels of sex hormones in the body.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hermaphrodiol CI brief — competitive landscape report
- Hermaphrodiol updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Hermaphrodiol
What is Hermaphrodiol?
How does Hermaphrodiol work?
What is the generic name of Hermaphrodiol?
What drug class is Hermaphrodiol in?
What development phase is Hermaphrodiol in?
What does Hermaphrodiol target?
Related
- Drug class: All androstenediol drugs
- Target: All drugs targeting Corticosteroid-binding globulin, Sex hormone-binding globulin, Androgen receptor
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing